chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Passing out; Window of blurry vision before passing out for about 30 seconds; Upon regaining consciousness, patient immediately vomited; Fever; Feeling achy; Chills; Tired; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (Passing out) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 044B2V) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.  Concomitant products included ETHINYLESTRADIOL, FERROUS FUMARATE, NORETHISTERONE ACETATE (LO LOESTRIN FE) for Birth control.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced LOSS OF CONSCIOUSNESS (Passing out) (seriousness criterion medically significant), VISION BLURRED (Window of blurry vision before passing out for about 30 seconds), VOMITING (Upon regaining consciousness, patient immediately vomited), PYREXIA (Fever), MYALGIA (Feeling achy), CHILLS (Chills) and FATIGUE (Tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, LOSS OF CONSCIOUSNESS (Passing out), VISION BLURRED (Window of blurry vision before passing out for about 30 seconds), VOMITING (Upon regaining consciousness, patient immediately vomited), PYREXIA (Fever), MYALGIA (Feeling achy), CHILLS (Chills) and FATIGUE (Tired) outcome was unknown.            Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Facial flushing in recovery area. no respiratory distress or itching. Pt given Benadryl 50 mg PO. VSS. Patient refused transport to hospital. Husband was a previous EMS and wanted to take her home.
Pt vaccinated w/dose of Hep B Vax (recomb); 1 day following vax pt exp hypotension; It was felt that the pt's exp was life-threatening;
sometimes it itches, sometimes it does not; allergic reaction; has some psoriasis on the back and the sides of the ribs; like a rash all over the body, mostly in the lower legs, it's like circle light spots, they are like little round spots, the middle section is like dry. They spreaded in her arms also, but the ones on her legs can really be seen, they're pretty big; This spontaneous case was reported by a nurse and describes the occurrence of RASH PRURITIC (sometimes it itches, sometimes it does not), HYPERSENSITIVITY (allergic reaction), PSORIASIS (has some psoriasis on the back and the sides of the ribs) and RASH (like a rash all over the body, mostly in the lower legs, it's like circle light spots, they are like little round spots, the middle section is like dry. They spreaded in her arms also, but the ones on her legs can really be seen, they're pretty big,) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Psoriasis (psoriasis since before this but only on the head, never in her body). Concomitant products included METFORMIN, ATORVASTATIN and ATENOLOL for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (sometimes it itches, sometimes it does not), HYPERSENSITIVITY (allergic reaction), PSORIASIS (has some psoriasis on the back and the sides of the ribs) and RASH (like a rash all over the body, mostly in the lower legs, it's like circle light spots, they are like little round spots, the middle section is like dry. They spreaded in her arms also, but the ones on her legs can really be seen, they're pretty big,). At the time of the report, RASH PRURITIC (sometimes it itches, sometimes it does not), HYPERSENSITIVITY (allergic reaction), PSORIASIS (has some psoriasis on the back and the sides of the ribs) and RASH (like a rash all over the body, mostly in the lower legs, it's like circle light spots, they are like little round spots, the middle section is like dry. They spreaded in her arms also, but the ones on her legs can really be seen, they're pretty big,) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided. Patient noticed after dose started having rash all over body,mostly in the lower legs, circle light spots, On April  patient went to the doctor and confirmed it was an allergic reaction and gave some treatment for it.
Pregnancy 1 week post COVID vaccination #2. Miscarriage at 6-7weeks. Managed with expectant management.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose01/07/21 2nd dose01/28/21 Diagnosed covid positive:09/15/21 Symptom onset:09/14/21 Exposure: Symptoms:cough,fatigue,muscle aches,sore throat,runny nose, HA
Pt has clinical varicella. He was exposed at daycare about 15 days previously.
Information has been received from a registered nurse concerning a 11-year-old white male with a cefaclor (CECLOR) allergy and no medical history who on 06-Aug-1996 was vaccinated in the right arm with a first dose of varicella virus vaccine live (lot #616997/1656B). Concomitant vaccination on the same day in the left arm included a second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot 3613410/0103D). There was no other concomitant medication. There was no illness at the time of vaccination. The reporter indicated that the patient developed "breakthrough varicella" after being vaccinated in the past. It was noted that the symptoms started a few days before being seen on 27-May-2003 and included "several lesions." The patient was treated with diphenhydramine hydrochloride (Benadryl) and acetaminophen (Tylenol) as needed. It was also indicated that a prescription drug was required. The symptoms had not completely resolved and at the time of the report, the patient had not recovered. Follow-up information from the registered nurse indicated that the patient developed many scattered varicella lesions the trunk. There were no diagnostic tests or laboratory results. It was noted that the patient recovered (also reported as unknown). Follow-up information from the registered nurse indicated that as of 11-Jul-2003 there were no other problems to date related to the varicella experience. No further information is expected. The nurse also reported a similar experience in a female child after vaccination with a dose of varicella virus vaccine live (WAES #0306USA00402). It was noted that the children attended the same school and the reporter notified the school of the children's status.
This case was reported by a other health professional via call center representative and described the occurrence of injection site warmth in a adult female patient who received Herpes SHINGRIX (batch number 539A2, expiry date 30th March 2020) for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site warmth, injection site erythema, injection site swelling and intramuscular formulation administered by other route. On an unknown date, the outcome of the injection site warmth, injection site erythema, injection site swelling and intramuscular formulation administered by other route were unknown. It was unknown if the reporter considered the injection site warmth, injection site erythema and injection site swelling to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The healthcare professional reported that her pharmacist vaccinated SHINGRIX into the fat instead of intramuscular, which led to inappropriate route of vaccination. The vaccination site was swollen up, quite red and hot.
Late 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Late 2nd dose) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Late 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Late 2nd dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was reported.
Pt was evaluated by Dr. on March 7, 2018. HPI: She began with rash yesterday  -- she has had cold s/s -- no fever since yesterday -- she did receive her Varicella vaccine on 2/24/18, 10 days prior to rash developing. INTEGUMENTARY: Positive for rash. SKIN: a rash is noted on the scalp, on the face (forehead), on the chest, and on the back; the color is mainly pink and red; it is best characterized as macular and vesicular. ASSESSMENT 052.7 B01.9  Varicella -- vaccine induced DDx. PLAN: Varicella Discussed in detail -- some concern for mom who is pregnant and has not had chickenpox in the past. Recommend for mom to wear a mask around patient until lesions have resolved and to avoid touching the lesions if they open up. MEDICATIONS: Advised to take OTC TYLENOL (acetaminophen) and ibuprofen. RECOMMENDATIONS given include: increase fluids and monitor I's and O's. FOLLOW-UP: Schedule follow-up appointments on a p.r.n. basis. Patient Recommendations: For Varicella: Use acetaminophen (TYLENOL) as needed for pain or fever. Use ibuprofen (ADVIL or MOTRIN) to help with pain, fever, or swelling. Schedule follow-up appointments as needed.
Buzzing feeling in diaphragm. Sweating, calminess, chills, and shortness of breath, and dizziness occurred for about 5 minutes for a period of 30 minutes.
Over the course of the night into the next morning red and hot to the touch, fever was swollen the size of a ping pong ball redness, itching and pain down arm through rib cage. Did not contact doctor contacted pharmacy.
Patient was given dose one of Moderna vaccine this morning. Patient returned to our site around 1230 pm with ?facial swelling.? He also reported throat itching and tightness.
Information has been received from a licensed practical nurse concerning her female coworker who on 10-APR-2009 was splashed with VARIVAX (Merck) in her eyes while withdrawing the vaccine.  She felt little burning when some of the liquid had gotten into her eyes.  The patient sought unspecified medical attention. At the time of reporting the patient was recovering.  Information has been received from a licensed practical nurse concerning her female coworker who on 10-APR-2009 was splashed with VARIVAX (Merck) in her eyes while withdrawing the vaccine.  She felt little burning when some of the liquid had gotten into her eyes.  The patient sought unspecified medical attention.  At the time of reporting the patient was recovering.  Follow-up information was received from a licensed visiting nurse concerning a 40 year old patient who is a registered nurse.  It was reported that the registered nurse was drawing up VARIVAX (Merck) upon injection diluent into VARIVAX (Merck) vial and the needle popped of the syringe the contents of the vial sprayed back into her face.  It was reported that the registered nurse's eyes were flushed for 15 minutes.  No laboratory diagnostic studies were performed.  At the time of reporting no serious criteria had been noted and the registered nurse was recovered.  No further information is available.
Vax type - Hep B  Eye pain. Painful to move them. Hot, burning sensation of body. Light sensitivity. Could not watch TV. Rushed to Ophthalmologist that evening. Test showed white dots in each eye, similar to conjunctivitis. Prescribed medications. Read to be a possible side effect to HepB vaccine. Returned to Ophthalmologist Dr who agreed there could be a correlation between symptoms and HepB vax. Also symptoms of sore throat dx'd by Dr.
Dizziness, Headache, Myalgia, Fever, Numbness in arms , face and lips Narrative: Receive vaccine on 7/27/2021. That night had fever, body ache and joint pain. Same symptoms the next day. on Thursday 7/29/2021 started having a headache. On Friday had headache and extreme vertigo. Then on Friday experienced numbness in arms, face, and lip with the extreme vertigo and headache. Went to the local hospital that night and was admitted.
Breakthrough COVID  70-year-old on IVIG every 6 weeks He started having fever, cough, congestion 2 days ago. He had a temperature of 100.2. His lactic acid was 2 and now is 1.2.  His white cell count is 63,000 with 87% neutrophils.  He is oxygenating at 99% on room air.  Chest x-ray shows no acute findings.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 25-OCT-2015 10:25, the patient was vaccinated with improperly stored RECOMBIVAX HB with lot number: L016427, expiry date: 13-APR-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. The high temperature and low temperature were 5.3 and -5.5 respectively. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 25Mar2021 at 14:30 as dose 1, single (Lot number: EP7534), in left arm, on 15Apr2021 at 14:30 as dose 2, single (Lot number: ER8734), in left arm, on 21Oct2021 at 14:30 as dose 3 (booster), single (Lot number: FC3184), in left arm and on 20May2022 at 14:30 as dose 4 (booster), single (Lot number: FK9894) at the age of 61 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Obesity" (unspecified if ongoing); "asthma" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing). Concomitant medication(s) included: OZEMPIC, start date: 22Jul2022; SYNTHROID, start date: 25Mar2022; CYTOMEL, start date: 21Jan2022. Past drug history included: Valium, reaction(s): "known allergies: Valium". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jan2023) positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 11Jan2023 to 15Jan2023.
PT WAS HEADED TO EXIT AFTER VACCINATION AND FELT AN "ABOVE THE WASTE FLUSHED FEELING" AND LIGHTHEADEDNESS. STAFF ASSITED PT INTO WC AND PT WAS TRANSPORTED TO MED OBS AT 1535. WHEN PT ARRIVED TO OBS SYMPTOMS WERE IMPROVING. WATER GIVEN. SYMPTOMS RESOLVED. PT RELEASED BY SELF AT 1620. PT ESCORTED TO EXIT BY STAFF WITH NO FURTHER ISSUES. VITALS AS FOLLOWS: 1538 BP 110/67 HR 69 SPO2 98 1543 BP 111/71 HR 63 SPO2 97 1554 SITTING BP 106/73 HR 56 SPO2 100 1600 SITTING BP 109/72 HR 64 SPO2 99 1611 STANDING BP 107/75 HR 61 SPO2 96
This is a spontaneous report from a contactable consumer (parent). A 19-year old male patient received two doses of TRUMENBA on an unspecified date, at single dose, for immunization. Relevant medical history and concomitant medications were unknown. The patient experienced a "slight reaction, arm hurt for an hour after the second dose". Clinical outcome of the event was unknown at time of this report. The information on the lot number has been requested.
Temp of 100.4 off and on for 24 hours; Sore arm; Slight redness; Chills; Headache; Tiredness - slept for 20 out of 24 hours post injection; This is a spontaneous report from a contactable Other HCP (patient). A 51-year-old (non-pregnant) female patient received BNT162B2 (Solution for injection, Lot number: EL9265) via unknown route of administration on 03Feb2021 at 10.45 AM first dose at right arm, single dose for COVID-19 immunisation. The patient's medical history included Covid (prior to vaccination). The concomitant medications were not reported. On 03Feb2021 at 09:00 PM, patient experienced sore arm, slight redness, chills, headache, tiredness (slept for 20 out of 24 hours post injection) and temperature of 100.4 off and on for 24 hours. The patient did not receive any treatment for the events. The outcome of the events was recovering.
2 hrs after pt had Hep A and Boostrix pt had involuntary twitching of upper extremities. Resolved 1 hr after Cogentin given orally. Dystonic reaction?
Pfizer Bivalent COVID vaccine given instead of primary series dose during combined flu/COVID clinic at the County Jail. After confirming that no primary series was in the immunization registry, nursing staff confirmed with client that she did not have any previous doses. Client was informed that she will still need another dose to complet primary series and that bivalent dose was given in error. No re-vaccination required according to CDC. Primary dose #2 will be given in 3-4 weeks, and jail nursing staff will monitor patient.
The affected arm began to get red, hot and swollen. The area measures 3 X 6 inches on the arm. Pt also complained of more fatigue than usual and some disorientation. Pt advised to apply cool compresses and exercise the affected arm. Take Benadryl and call family physician for further instructions.  Pt called for follow up and there was no redness or swelling, still tender and warm. Pt did not call family physician because it was better.
Information has been received from a nurse mid-wife concerning a patient who on an unspecified date was vaccinated with a third dose of GARDASIL (lot number, injection site and route not reported).  Subsequently the patient fainted.  It was unknown whether the patient sought medical attention.  This is one of two reports received from the same source.  Additional information has been requested.
Information has been received on 05-FEB-2019 from a lawyer and a male patient regarding a case in litigation. The patient was inoculated with ZOSTAVAX (lot number and expiration not reported) in 2015 at a medical center, as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster, also known as shingles and other complications. The patient was treated at a medical center for a blistering vesicular outbreak which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the vaccine ZOSTAVAX and/or despite receiving ZOSTAVAX for prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Upon standing post-vaccination, patient fell into the floor, eyes rolled back into his head, and was convulsing. Upon regaining  his whereabouts, patient stated he did not recall anything that had happened. He had impaired vision, tinnitus,  and was ashen in color. I was able to get the patient into a chair and he experienced two more episodes within 5 minutes. 911 was called. Patient requested water and it was provided. Paramedics arrived and conducted multiple tests (blood glucose, blood oxygen, blood pressure, heart monitoring). Patient refused referral to the local hospital and left the pharmacy within 30-45 minutes after the  incident without any further problems.
Started to feel bad when I left after 15 minutes wait time. Upon leaving I almost pulled into the hospital parking lot to wait, but decided to try and drive home. I began to feel light headed, dizzy, dry mouth, it felt hard to swallow. I knew I did not feel well so I drove myself to the fire station that was closest to me. They took my blood pressure upon arrival and it  was 141/93.  My normal blood pressure is around 116/63, so it was considerably high. I do not have a history of high blood pressure. The morning of the vaccination I had, had a very small cup of coffee and had eaten a piece of raisin bread. I had also taken two 250 mg generic acetaminophen tablets with 65mg caffeine prior to the vaccination. I also experienced chills and a low grade fever of 100 degrees.
Erythema, blistering, 30 mm induration at injection site x 96 hours. Antihistamines topical, PO used. Ice applied with relief.
12/29 To ED with lightheadedness and dizziness. Started yesterday. She has not passed out. She told the nurse she's been having black stools. She reports cough and shortness of breath. She states she had mechanical fall week ago and still has some pain in her tailbone. 12/30 COVID + Test. Decadron started. Dx with Acute hypoxic respiratory failure secondary to COVID.  1/3 Progressed well, discharged home.
Note:  patient immunocompromised s/p heart transplant.  Developed inflammation/?myositis in both legs; refused to move them.  Admitted, given iv antibiotics x48 hours, then oral abx.  Recovered uneventfully.  10/15/2007 MR received from PCP. Vax record included and lot numbers updated in VAERS database. Pt in for WCC and vax on 9/17/2007.  Seen again 9/19/07 for fever, decreased po intake, diarrhea, and "won't move body since 9/17/07". (+) bladder incontinence because of refusal to get up.  PE (+) for refusal to move and generalized tenderness of the lower extremities.  Admited to hospital for presumed myositis.    01/14/2008 MR received for DOS 9/19-22/2007 with D/C DX:  Myositis.  Child presented for direct admit for c/o fever, pain and refusal to walk.    PE (+) for tenderness from the L hip to knee.  Red streaking noted on 9/20/07.  Txd with abx with good result.  Pt became hyperkalemic during admit with EKG changes which resolved with IVF changes and kayexolate.  D/C on po abx.
about 2 minutes after receiving the vaccine i felt a heatwave starting at left arm going through my whole body, with dizziness and and a feeling of panic. was about to ask for water but panic feeling subsided after roughly one minute. slight dizziness remained.  15 minutes later I felt a slight numbness in my face and right hand
Prescribing information states influenza A (H1N1) is indicated JT for individuals age 2-49.
Information has been received from a physician concerning a pt between 12-15 months of age who on an unspecified date was vaccinated with a dose of MMR II/Varicella vaccine. Subsequently, the pt broke out in an allergic type, measles rash all over the body. Unspecified medical attention was sought. No further information was provided. There was no product quality complaint involved. Additional information has been requested.
Started  day after injection and worsened 2 days after.  Large raised rash/large hive that started at the top of my arm and itched (ice helped) Rash proceeded to get larger and move down my arm. Day 4 on started to lessen. Advil taken for pain.